HLB bioStep Co.,Ltd. Statistics

Total Valuation

HLB bioStep Co.,Ltd. has a market cap or net worth of KRW 168.81 billion. The enterprise value is 160.53 billion.

Market Cap	168.81B
Enterprise Value	160.53B

Important Dates

The next estimated earnings date is Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

HLB bioStep Co.,Ltd. has 84.20 million shares outstanding. The number of shares has increased by 7.43% in one year.

Current Share Class	n/a
Shares Outstanding	84.20M
Shares Change (YoY)	+7.43%
Shares Change (QoQ)	-8.19%
Owned by Insiders (%)	4.70%
Owned by Institutions (%)	4.61%
Float	65.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.92
PB Ratio	1.45
P/TBV Ratio	1.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-32.50
EV / Sales	2.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.67

Financial Position

The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.29.

Current Ratio	1.37
Quick Ratio	1.19
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	-1.65
Interest Coverage	-6.58

Financial Efficiency

Return on equity (ROE) is -5.00% and return on invested capital (ROIC) is -3.25%.

Return on Equity (ROE)	-5.00%
Return on Assets (ROA)	-3.05%
Return on Capital (ROIC)	-3.25%
Revenue Per Employee	378.37M
Profits Per Employee	-32.92M
Employee Count	150
Asset Turnover	0.33
Inventory Turnover	11.81

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-29.15%
50-Day Moving Average	2,100.32
200-Day Moving Average	2,743.38
Relative Strength Index (RSI)	43.57
Average Volume (20 Days)	232,802

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HLB bioStep Co.,Ltd. had revenue of KRW 56.76 billion and -4.94 billion in losses. Loss per share was -59.79.

Revenue	56.76B
Gross Profit	39.84B
Operating Income	-8.28B
Pretax Income	-5.37B
Net Income	-4.94B
EBITDA	-3.87B
EBIT	-8.28B
Loss Per Share	-59.79

Full Income Statement

Balance Sheet

The company has 46.50 billion in cash and 34.47 billion in debt, giving a net cash position of 12.03 billion or 142.91 per share.

Cash & Cash Equivalents	46.50B
Total Debt	34.47B
Net Cash	12.03B
Net Cash Per Share	142.91
Equity (Book Value)	120.19B
Book Value Per Share	1,383.01
Working Capital	16.69B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.10 billion and capital expenditures -10.84 billion, giving a free cash flow of -20.94 billion.

Operating Cash Flow	-10.10B
Capital Expenditures	-10.84B
Free Cash Flow	-20.94B
FCF Per Share	-248.65

Full Cash Flow Statement

Margins

Gross margin is 70.20%, with operating and profit margins of -14.59% and -8.70%.

Gross Margin	70.20%
Operating Margin	-14.59%
Pretax Margin	-9.46%
Profit Margin	-8.70%
EBITDA Margin	-6.81%
EBIT Margin	-14.59%
FCF Margin	n/a

Dividends & Yields

HLB bioStep Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.43%
Shareholder Yield	-7.43%
Earnings Yield	-2.98%
FCF Yield	-12.40%

Dividend Details

Stock Splits

The last stock split was on May 31, 2022. It was a forward split with a ratio of 9.

Last Split Date	May 31, 2022
Split Type	Forward
Split Ratio	9

Scores

HLB bioStep Co.,Ltd. has an Altman Z-Score of 3.47.

Altman Z-Score	3.47
Piotroski F-Score	n/a